Focusing on IL-6/STAT3 Pathway shows the approach of anti-IL-6 antibody (tocilizumab) in the treatment of multiple hydrocephalus. Current Opinion [Internet]. 10. Dezember 2021 [zitiert 11. Oktober 2026];1(01):15-9. Verfügbar unter: https://currentopinion.be/index.php/co/article/view/14